BioCentury | Sep 17, 2012
Product Development

Excited about cycling

New synthesis and screening technologies and the allure of access to previously undruggable targets are driving an explosion of new company formation and deal-making around macrocycles and constrained peptides. While it remains to be seen...
BioCentury | Aug 5, 2010
Distillery Techniques

Technology: Markers

...enhancer I B cells inhibitor-z (NFKBIZ), ATPase H+/K+ exchanging a-polypeptide (ATP4A), germ cell associated 1 (GSG1...
...of gene expression profiles of tumors from patients with PDAC, six genes-KLF6, FOSB, NFKBIZ, ATP4A, GSG1...
Items per page:
1 - 2 of 2